what is Paxlovid course treatment
Paxlovid (ritonavir-boosted nirmatrelvir) is a preferred oral antiviral authorized for the treatment of mild-moderate COVID-19 illness. Patients take a combination of pills twice a day for 5 days.
Paxlovid(Nirmatrelvir/ritonavir) is recommended for adults and pediatric patients 12 years and older weighing at least 40 kg (88 lb) with positive SARS-CoV-2 test results who are at high risk for progression to severe COVID-19.
Treating COVID-19 Paxlovid course treatment
If you have COVID-19 and are more likely to get very sick from COVID-19, treatments are available that can reduce your chances of being hospitalized or dying from the disease.
Medications to treat COVID-19 must be prescribed by a healthcare provider and started as soon as possible after diagnosis to be effective. Contact a healthcare provider right away to determine if you are eligible for treatment, even if your symptoms are mild right now.
There are no reviews yet.